Tracking bladder cancer recurrence with repeated urine tests
Part of Cancer, Kidney & urinary clinical trials.
This study follows people with past bladder cancer to see how bladder cancer comes back over time. You would provide urine samples at several visits, which helps researchers evaluate urine tests that may spot recurrence earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve been diagnosed with urothelial bladder cancer, or it came back, within the last 3 years
- You can attend 4 visits in a row and give a urine sample each time
- You can provide a urine sample yourself (not from a catheter)
- You are 18 years old or older and can sign written consent
- You can follow the study schedule and instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
This study tests a new non-invasive urine test (Xpert Bladder Monitor) to see if it can catch bladder cancer coming back early, reducing the need for frequent cystoscopy. It is for people with high-grade or high-risk non-muscle invasive bladder cancer who have had or are still having BCG treatment.
This trial tests a new urine test (BCDx) to see if it can catch bladder cancer coming back in people with non-muscle invasive bladder cancer (NMIBC) who are already having regular check-ups. You would give a urine sample before your routine cystoscopy, and the results may help doctors monitor your cancer more easily.
This study uses a urine test to detect small amounts of cancer DNA (microscopic residual disease) after treatment, to see if it can catch a recurrence earlier than standard scans or cystoscopy. It includes four groups of people with different types and stages of urothelial cancer (in the kidney, ureter, or bladder) to see how well the test works for each group.
This Phase 2 study tests whether urine tests can help monitor “non-muscle-invasive” bladder cancer without doing as many invasive bladder scopes (cystoscopies). If you qualify, you may be able to replace some scope visits with urine sample testing while still keeping close watch for cancer coming back.
This study tests whether a special urine testing approach can better identify and sort risk in people (especially veterans) who were referred to urology for blood in the urine. It may help doctors decide who needs more urgent follow-up and which next steps to take.
Hear when a new Urothelial Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.